Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Moodys
Chinese Patent Office
US Army
McKinsey
Colorcon
Healthtrust
Baxter
Farmers Insurance

Generated: July 18, 2018

DrugPatentWatch Database Preview

Acetazolamide sodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for acetazolamide sodium and what is the scope of acetazolamide sodium patent protection?

Acetazolamide sodium
is the generic ingredient in two branded drugs marketed by Hospira, Mylan Asi, Par Sterile Products, West-ward Pharms Int, X Gen Pharms, Emcure Pharms Ltd, and Teva Womens, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for acetazolamide sodium. Four suppliers are listed for this compound.
Pharmacology for acetazolamide sodium
Synonyms for acetazolamide sodium
1424-27-7
429ZT169UH
59-66-5 (Parent)
Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-, monosodium salt
ACETAMIDE, N-(5-SULFAMOYL-1,3,4-THIADIAZOL-2-YL)-, MONOSODIUM SALT
Acetazolamide sodium (JAN)
Acetazolamide sodium [USAN:JAN]
Acetazolamide sodium salt
Acetazolamide, Monosodium Salt
C4H6N4O3S2.Na
CHEBI:31163
CHEMBL1200814
D01196
Diamox sodium
DTXSID00162031
HE025730
HE310699
LS-10228
MRSXAJAOWWFZJJ-UHFFFAOYSA-M
N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide monosodium salt
SCHEMBL40813
sodium [(5-acetamido-1,3,4-thiadiazol-2-yl)sulfonyl]azanide
Sodium acetazolamide
UNII-429ZT169UH

US Patents and Regulatory Information for acetazolamide sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 205358-001 Jun 20, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Asi ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 200880-001 May 9, 2012 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int ACETAZOLAMIDE SODIUM acetazolamide sodium INJECTABLE;INJECTION 040089-001 Feb 28, 1995 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Womens DIAMOX acetazolamide sodium INJECTABLE;INJECTION 009388-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Citi
McKinsey
Argus Health
Medtronic
Moodys
Cipla
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.